Ewa Gonczol

Title: Ewa Gonczol: Innovator in Vaccine Development

Introduction

Ewa Gonczol is a prominent inventor based in Rosemont, PA (US), known for her significant contributions to the field of vaccine development. With a total of 2 patents, she has made strides in creating innovative solutions to combat viral infections.

Latest Patents

Ewa Gonczol's latest patents include a recombinant cytomegalovirus vaccine. The first patent provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit and for the expression of non-structural immediate-early exon 4 proteins. This recombinant HCMV-expressing adenovirus is useful as a vaccine. The second patent also focuses on a recombinant cytomegalovirus vaccine, offering a similar expression system for the HCMV gB subunit and its immunogenic fragments, further emphasizing its potential as a vaccine.

Career Highlights

Throughout her career, Ewa Gonczol has worked with esteemed organizations such as The Wistar Institute and the United States of America as represented by the Department of Health. Her work has been pivotal in advancing the understanding and development of vaccines.

Collaborations

Ewa has collaborated with notable colleagues, including Robert P. Ricciardi and Stanley A. Plotkin, who have contributed to her research and innovations in the field.

Conclusion

Ewa Gonczol's work in vaccine development showcases her dedication to improving public health through innovative solutions. Her patents reflect her commitment to advancing medical science and combating viral diseases.